IL157588A0 - Carbamate compounds for use in preventing or treating psychotic disorders - Google Patents

Carbamate compounds for use in preventing or treating psychotic disorders

Info

Publication number
IL157588A0
IL157588A0 IL15758802A IL15758802A IL157588A0 IL 157588 A0 IL157588 A0 IL 157588A0 IL 15758802 A IL15758802 A IL 15758802A IL 15758802 A IL15758802 A IL 15758802A IL 157588 A0 IL157588 A0 IL 157588A0
Authority
IL
Israel
Prior art keywords
preventing
psychotic disorders
carbamate compounds
treating psychotic
treating
Prior art date
Application number
IL15758802A
Other languages
English (en)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of IL157588A0 publication Critical patent/IL157588A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15758802A 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders IL157588A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27188901P 2001-02-27 2001-02-27
PCT/US2002/006119 WO2002067927A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders
US10/081,761 US6541513B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders

Publications (1)

Publication Number Publication Date
IL157588A0 true IL157588A0 (en) 2004-03-28

Family

ID=26765939

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15758802A IL157588A0 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders
IL157588A IL157588A (en) 2001-02-27 2003-08-26 Carbamate compounds for use in preventing or treating psychotic disorders

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL157588A IL157588A (en) 2001-02-27 2003-08-26 Carbamate compounds for use in preventing or treating psychotic disorders

Country Status (25)

Country Link
US (1) US6541513B2 (zh)
EP (1) EP1401424B1 (zh)
JP (1) JP4276841B2 (zh)
KR (1) KR100886578B1 (zh)
CN (1) CN1262271C (zh)
AR (1) AR032876A1 (zh)
AT (1) ATE346597T1 (zh)
AU (1) AU2002242296B2 (zh)
BR (1) BR0207829A (zh)
CA (1) CA2439480C (zh)
CZ (1) CZ302412B6 (zh)
DE (1) DE60216457T2 (zh)
DK (1) DK1401424T3 (zh)
ES (1) ES2275844T3 (zh)
HU (1) HUP0303342A3 (zh)
IL (2) IL157588A0 (zh)
MX (1) MXPA03007722A (zh)
NO (1) NO20033801L (zh)
NZ (1) NZ527991A (zh)
PL (1) PL365021A1 (zh)
PT (1) PT1401424E (zh)
RS (1) RS51056B (zh)
RU (1) RU2302240C2 (zh)
TW (1) TWI251486B (zh)
WO (1) WO2002067927A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2003445A3 (cs) * 2000-07-21 2004-08-18 Ortho@Mcneilápharmaceuticalźáinc Karbamátové sloučeniny pro prevenci nebo léčbu neuropatické bolesti a bolesti asociované s histaminovou a migrenózní bolestí hlavy
MXPA03007720A (es) * 2001-02-27 2004-11-12 Johnson & Johnson Compuestos de carbamato para su uso en la prevencion o el tratamiento de transtornos de ansiedad.
NZ527990A (en) * 2001-02-27 2006-01-27 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating neurodegenerative disorders
RU2303445C2 (ru) 2001-07-16 2007-07-27 Орто-Макнейл Фармасьютикал, Инк. Карбаматные соединения для применения для предотвращения или лечения невропатической боли и боли, связанной с кластерной и мигреневой головной болью
WO2005107719A2 (en) * 2004-05-06 2005-11-17 Sandoz Ag Pharmaceutical composition comprising hydrophobic drug having improved solubility
AU2005335241B9 (en) * 2005-07-26 2012-12-20 Sk Biopharmaceuticals Co., Ltd. Methods for treating substance-related disorders
CN101568362A (zh) * 2006-10-30 2009-10-28 詹森药业有限公司 治疗抑郁症的方法
CN101568333A (zh) * 2006-10-31 2009-10-28 詹森药业有限公司 广泛性发育障碍的治疗
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN109939092B (zh) 2013-03-12 2022-03-22 比皮艾思药物研发有限公司 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物
CN105164103B (zh) * 2013-03-12 2019-12-06 比皮艾思药物研发有限公司 苯基氨基甲酸酯化合物和含有其的预防或治疗记忆缺失相关疾病的组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5492930A (en) * 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
BR0207829A (pt) 2004-06-22
NZ527991A (en) 2005-04-29
TWI251486B (en) 2006-03-21
RU2302240C2 (ru) 2007-07-10
CZ20032297A3 (cs) 2004-06-16
RS51056B (sr) 2010-10-31
ES2275844T3 (es) 2007-06-16
CA2439480C (en) 2011-04-26
AR032876A1 (es) 2003-11-26
KR100886578B1 (ko) 2009-03-05
JP4276841B2 (ja) 2009-06-10
EP1401424B1 (en) 2006-11-29
US20020165272A1 (en) 2002-11-07
DE60216457D1 (de) 2007-01-11
IL157588A (en) 2009-12-24
EP1401424A1 (en) 2004-03-31
PT1401424E (pt) 2007-02-28
US6541513B2 (en) 2003-04-01
DK1401424T3 (da) 2007-02-26
NO20033801D0 (no) 2003-08-26
WO2002067927A1 (en) 2002-09-06
DE60216457T2 (de) 2007-09-20
CA2439480A1 (en) 2002-09-06
KR20030076713A (ko) 2003-09-26
MXPA03007722A (es) 2004-11-12
RU2003128983A (ru) 2005-03-10
PL365021A1 (en) 2004-12-27
HUP0303342A2 (hu) 2004-01-28
NO20033801L (no) 2003-10-22
ATE346597T1 (de) 2006-12-15
CN1262271C (zh) 2006-07-05
CN1505507A (zh) 2004-06-16
AU2002242296B2 (en) 2006-06-29
HUP0303342A3 (en) 2012-07-30
JP2004523556A (ja) 2004-08-05
RS67503A (en) 2006-12-15
CZ302412B6 (cs) 2011-05-04

Similar Documents

Publication Publication Date Title
IL173439A0 (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
PT2311466E (pt) Compostos antimicrobianos e métodos para a sua utilização
ZA200503967B (en) Agent for preventing or treating neuropathy
GB0112343D0 (en) Well treatment
IL160208A0 (en) Amidine derivatives for treating amyloidosis
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
HK1067305A1 (en) Carbamate compounds for use in preventing or treating movement disorders
HK1060516A1 (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders
PL368556A1 (en) Methods for treating or preventing skin disorders using cd2-binding agents
HUP0303261A3 (en) Carbamate compounds for use in preventing or treating bipolar disorder
IL157588A0 (en) Carbamate compounds for use in preventing or treating psychotic disorders
IL157593A0 (en) Carbamate compounds for use in the treatment of pain
HUP0303243A3 (en) Carbamate compounds for use in preventing and treating bipolar disorder
EP1558238A4 (en) BETA-HYDROXYPHENYL ALDYLAMINE AND ITS USE FOR THE TREATMENT OF GLAUCOMA
GB2386602B (en) Anti-loading treatments
EP1419236A4 (en) METHODS OF TREATING OR PREVENTING SCLEROSIS BY USE OF CD2-BINDING AGENTS
PT1698338E (pt) S-metil-di-hidro-ziprasidona para o tratamento de distúrbios psiquiátricos
AU2002342188A8 (en) Methods and compositions for treating flavivirus-mediated disease
ZA200307477B (en) Carbamate compounds for use in preventing or treating movement disorders.
GB2397018B (en) Combination therapy for treating disease
HUP0402141A3 (en) Herbicidal composition and process for its use
ZA200307473B (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders.
EP1372630A4 (en) AGENT FOR THE TREATMENT OF THE HYPERACTIVE BLADDER
TWI318876B (en) Carbamate compounds for use in preventing or treating bipolar disorder
GB0130694D0 (en) Treatment